Kala-azar, also known as visceral leishmaniasis (VL), is a disease caused by Leishmania
infantum and L. donovani. Patients experience symptoms such as fever, weight loss …

The mammalian immune system packs serious punch against infection but can also cause
harm: for example, coronavirus disease 2019 (COVID-19) made headline news of the …

Leishmania infections are global, occurring in 98 countries and all World Health
Organization (WHO) regions with 600 million to 1 billion people at risk of infection. Visceral …

Background Control of leishmaniasis in the Mediterranean Basin relies on the active
contributions from researchers in the fields of animal, human and environmental health. The …

Leishmaniasis is an important vector-borne disease that represents a serious public health
problem, including in Sicily (Italy), which is considered an endemic area. We collected …

Background Asymptomatic infection is the most common outcome of exposure to
Leishmania parasites. In the Mediterranean region, where Leishmania infantum is endemic …

Leishmaniasis is a disease caused by protozoa of the genus Leishmania. Treatment options
are limited, and there are frequent cases of treatment failure and clinical relapse. To …

Inflammation is an integral part of defense against most infectious diseases. These
pathogen-induced immune responses are in very many instances strongly influenced by …

Background: Leishmaniasis is a neglected zoonosis produced by 20 different flagellated
parasites of the Leishmania genus, a protozoan transmitted to humans and other vertebrates …

Background Mucosal Leishmaniasis (ML), a neglected tropical disease caused by
Leishmania parasites, impairs the quality of life of under-resourced populations in South …